MRC National Institute for Medical Research, London

• Home
• Publications
• Influenza Bibliography

• Annual Report and Prospectus
• Latest publications
• Influenza Bibliography
• Mill Hill Essays

Influenza Bibliography

November 2009 : Vol 39 No 11

Categories

• Clinical
• Diagnosis and detection
• Epidemiology
• Immunology and immunity
• Pandemics - planning and threats
• Structure, function and genetics
• Therapies and antivirals
• Vaccination and vaccines

Clinical

• Anonymous. (2009),
  A H1N1 flu meeting. Paris, June 29th.
  Medecine Et Maladies Infectieuses 39(9), 728-734.
• Anonymous. (2009),
  Kids and the flu.
  State Legislatures 35(9), 25.
• Anonymous. (2009),
  Masks might limit spread of swine flu.
  Consumer Reports 74(11), 12.
• Adcock, NJ, Rice, EW, Sivaganesan, M, Brown, JD, Stallknecht, DE and Swayne, DE. (2009),
  The use of bacteriophages of the family Cystoviridae as surrogates for H5N1 highly pathogenic avian influenza viruses in persistence and inactivation studies.
  Journal of Environmental Science and Health Part A-Toxic/Hazardous Substances & Environmental Engineering 44(13), 1362-1366.
• Ayala, E, Kagawa, FT, Wehner, JH, Tam, J and Upadhyay, D. (2009),
  Rhabdomyolysis associated with 2009 influenza A(H1N1).
  JAMA 302(17), 1863-4.
• Bai, Y-q, Xu, G, Gong, Z-l, Li, S-h, Xu, Y-c, Li, K and Xu, W-y. (2006),
  [Pathologic changes caused by highly pathogenic H5N1 avian influenza virus: postmortem study of a case].
  Chung-Hua Ping Li Hsueh Tsa Chih - Chinese Journal of Pathology 35(9), 545-8.
• Barlow, GD. (2009),
  Swine flu and antibiotics.
  Journal of Antimicrobial Chemotherapy 64(5), 889-894.
• Bouscambert-Duchamp, M, Lina, B and Morfin, F. (2008),
  Avian influenza in children.
  Archives de Pediatrie 16(Suppl. 2), S101-S107.
• Burioni, R, Canducci, F and Clementi, M. (2009),
  Pregnancy and H1N1 infection.
  Lancet 374(9699), 1417-8.
• Buss, BF, Shinde, VM, Safranek, TJ and Uyeki, TM. (2009),
  Pediatric influenza-associated myositis - Nebraska, 2001-2007.
  Influenza and Other Respiratory Viruses 3(6), 277-285.
• Carter, CJ. (2006),
  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and toxoplasma gondii.
  Schizophrenia Bulletin 35(6), 1163-1182.
• Chang, HJ, Burke, AE and Glass, RM. (2009),
  JAMA patient page. Influenza.
  JAMA 302(17), 1926.
• Cheng, VCC, Lau, YK, Lee, KL, Yiu, KH, Chan, KH, Ho, PL and Yuen, KY. (2009),
  Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus.
  Journal of Infection 59(5), 366-370.
• Chevillotte, J. (2009),
  [New modalities of care in influenza A/H1N1].
  Revue de L'Infirmiere (153), 7.
• Davies, A, Jones, D, Bailey, M, Beca, J, Bellomo, R, Blackwell, N, Forrest, P, Gattas, D, Granger, E, Herkes, R, Jackson, A, McGuinness, S, Nair, P, Pellegrino, V, Pettila, V, Plunkett, B, Pye, R, Torzillo, P, Webb, S, Wilson, M and Ziegenfuss, M. (2009),
  Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome.
  JAMA-Journal of the American Medical Association 302(17), 1888-1895.
• De Rosa, FG, Montrucchio, C and Di Perri, G. (2009),
  Management of H1N1 influenza virus respiratory syndrome.
  Minerva Anestesiologica 75(11), 654-660.
• Doherty, PC and Turner, SJ. (2009),
  What do we know about influenza and what can we do about it?
  Journal of Biology 8(5), 46.
• Endmann, M, Becker, JC and Kunze, D. (2009),
  Benign acute myositis after influenza. A new form of benign acute childhood myositis?
  Monatsschrift Kinderheilkunde 157(10), 993-996.
• Fisun, AI, Kuchmin, AN, Akimkin, VG, Korotchenko, SI, Nikitin, AE, Volzhanin, VM, Ogarkov, PI and Obukhov, II. (2009),
  [Swine flu: epidemiology, diagnostics, treatment, and prophylaxis].
  Voenno-Meditsinskii Zhurnal 330(7), 46-54.
• Gerberding, JL. (2009),
  Influenza in 2009: new solutions, same old problems.
  JAMA 302(17), 1907-8.
• Gin, A and Kumar, A. (2009),
  H1N1 patients in ICU.
  CMAJ Canadian Medical Association Journal 181(8), 500.
• Gordon, SM. (2009),
  Update on 2009 pandemic influenza A (H1N1) virus.
  Cleveland Clinic Journal of Medicine 76(10), 577-582.
• Hajjar, LA, Schout, D, Galas, F, Uip, DE, Levin, ASS, Caiaffa, HH, Sakane, PT, Suslik, CA, Teixeira, JMD, Bonfa, E, Barone, AA, Martins, MD, Boulos, M and Auler, JOC. (2009),
  Guidelines on management of human infection with the novel virus influenza A (H1N1) - a report from the Hospital Das Clinicas of the University of Sao Paulo.
  Clinics 64(10), 1015-1024.
• Hui, DS, Chow, BK, Ng, SS, Chu, LCY, Hall, SD, Gin, T, Sung, JJY and Chan, MTV. (2009),
  Exhaled air dispersion distances during noninvasive ventilation via different respironics face masks.
  Chest 136(4), 998-1005.
• Jurawan, R, de Almeida, M, Smith, A and Weilert, F. (2009),
  Swine H1N1 influenza in a post liver transplant patient.
  New Zealand Medical Journal 122(1304), 107-11.
• Kett, JC and Loharikar, A. (2009),
  Influenza and parainfluenza.
  Pediatrics in Review 30(8), 326-7.
• Khan, Z, Hulme, J and Sherwood, N. (2009),
  An assessment of the validity of SOFA score based triage in H1N1 critically ill patients during an influenza pandemic.
  Anaesthesia 64(12), 1283-1288.
• Kiely, PM, Lian, KY, Napper, G and Lakkis, C. (2009),
  Influenza A(H1N1) and infection control guidelines for optometrists.
  Clinical and Experimental Optometry 92(6), 490-494.
• Kliachkina, IL. (2009),
  [Treatment of cough in acute respiratory virus infections and influenza by the patients of risk group].
  Voenno-Meditsinskii Zhurnal 330(7), 40-5.
• Kost, GJ, Hale, KN, Brock, TK, Louie, RF, Gentile, NL, Kitano, TK and Tran, NK. (2009),
  Point-of-care testing for disasters: needs assessment strategic planning, and future design.
  Clinics in Laboratory Medicine 29(3), 583-605.
• Kuehn, BM. (2009),
  CDC updates recommendations for protecting clinicians from influenza.
  JAMA 302(17), 1847.
• Kwong, KL, Lung, D, Wong, SN, Que, TL and Kwong, NS. (2009),
  Influenza-related hospitalisations in children.
  Journal of Paediatrics and Child Health 45(11), 660-664.
• Li, GX, Yilmaz, M, Kojicic, M, Fernandez-Perez, E, Wahab, R, Huskins, WC, Afessa, B, Truwit, JD and Gajic, O. (2009),
  Outcome of critically ill patients with influenza virus infection.
  Journal of Clinical Virology 46(3), 275-278.
• Loeb, M, Dafoe, N, Mahony, J, John, M, Sarabia, A, Glavin, V, Webby, R, Smieja, M, Earn, DJD, Chong, S, Webb, A and Walter, SD. (2009),
  Surgical mask vs N95 respirator for preventing influenza among health care workers a randomized trial.
  JAMA-Journal of the American Medical Association 302(17), 1865-1871.
• Louie, JK, Acosta, M, Winter, K, Jean, C, Gavali, S, Schechter, R, Vugia, D, Harriman, K, Matyas, B, Glaser, CA, Samuel, MC, Rosenberg, J, Talarico, J and Hatch, D. (2009),
  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.
  JAMA-Journal of the American Medical Association 302(17), 1896-1902.
• MacKenzie, D. (2009),
  Swine flu: fact versus fantasy.
  New Scientist 204(2732), 40-45.
• Mekki, FH. (2009),
  [About influenza and development of rheumatoid arthritis].
  Soins: La Revue de Reference Infirmiere (738), 51.
• Michaelis, M, Geiler, J, Klassert, D, Doerr, HW and Cinatl, J. (2009),
  Infection of human retinal pigment epithelial cells with influenza A viruses.
  Investigative Ophthalmology & Visual Science 50(11), 5419-5425.
• Mitka, M. (2009),
  Hand washing, a key anti-flu strategy, often neglected by health care workers.
  JAMA 302(17), 1850-1.
• Murray, R, Chandler, C, Clarkson, Y, Wilson, N, Baker, M and Cunningham, R. (2009),
  Sub-optimal hand sanitiser usage in a hospital entrance during an influenza pandemic, New Zealand, August 2009.
  Eurosurveillance 14(37), 2-4.
• Nau, J-Y. (2009),
  [Mysteries not resolved by A(H1N1)].
  Revue Medicale Suisse 5(216), 1793.
• Nau, J-Y. (2009),
  [Will you dare the diagnosis by telephone?].
  Revue Medicale Suisse 5(212), 1576.
• Ogawa, S, Yamamoto, Y, Yamada, M, Mase, M and Nakamura, K. (2009),
  Pathology of Whooper Swans (Cygnus cygnus) infected with H5N1 avian influenza virus in Akita, Japan, in 2008.
  Journal of Veterinary Medical Science 71(10), 1377-1380.
• Okunishi, J, Nishihara, Y, Maeda, S and Ikeda, M. (2009),
  In vitro evaluation of the antimicrobial activity of HM-242, a novel antiseptic compound.
  Journal of Antibiotics 62(9), 489-493.
• Payne, R, Darton, TC and Greig, JM. (2009),
  Systematic telephone triage of possible 'swine' influenza leads to potentially serious misdiagnosis of infectious diseases.
  Journal of Infection 59(5), 371-2.
• Pellowe, C. (2009),
  When should staff wear face masks?
  Nursing Times 105(34), 16.
• Robinson, S, Sutherland, H and Spooner, D. (2009),
  Preparing for swine flu: 10 questions that all nurses need to ask themselves.
  Nursing Times 105(34), 14-5.
• Scalera, NM and Mossad, SB. (2009),
  The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.
  Postgraduate Medicine 121(5), 43-47.
• Scherer, M. (2009),
  Inside the fight against a flu pandemic.
  Time 174(6), 24-9.
• Schmidt, WP, Wloch, C, Biran, A, Curtis, V and Mangtani, P. (2009),
  Formative research on the feasibility of hygiene interventions for influenza control in UK primary schools.
  BMC Public Health 9, 390.
• Schnitzler, SU and Schnitzler, P. (2009),
  An update on swine-origin influenza virus A/H1N1: a review.
  Virus Genes 39(3), 279-292.
• Shine, KI, Rogers, B and Goldfrank, LR. (2009),
  Novel H1N1 influenza and respiratory protection for health care workers.
  New England Journal of Medicine 361(19), 1823-5.
• Sperling, W and Biermann, T. (2009),
  Influenza H1N1 and the world wide economic crisis - a model of coherence?
  Medical Hypotheses 73(5), 664-666.
• Srinivasan, A and Perl, TM. (2009),
  Respiratory protection against influenza.
  JAMA 302(17), 1903-4.
• Stephens, I. (2009),
  Pandemic flu: implications for sexual and reproductive health services.
  Journal of Family Planning & Reproductive Health Care 35(4), 215-6.
• Su, LL, Chan, J, Chong, YS, Choolani, M, Biswas, A and Yong, EL. (2009),
  Pregnancy and H1N1 infection.
  Lancet 374(9699), 1417-8.
• Viscusi, DJ, Bergman, MS, Eimer, BC and Shaffer, RE. (2009),
  Evaluation of five decontamination methods for filtering facepiece respirators.
  Annals of Occupational Hygiene 53(8), 815-827.
• White, DB and Angus, DC. (2009),
  Preparing for the sickest patients with 2009 influenza A(H1N1).
  JAMA 302(17), 1905-6.
• Zosky, GR, Cannizzaro, V, Hantos, Z and Sly, PD. (2009),
  Protective mechanical ventilation does not exacerbate lung function impairment or lung inflammation following influenza A infection.
  Journal of Applied Physiology 107(5), 1472-1478.

Back to top

Diagnosis and detection

• Chiang, M-F, Lin, P-W, Lin, L-F, Chiou, H-Y, Chien, C-W, Chu, S-F and Chiu, W-T. (2008),
  Mass screening of suspected febrile patients with remote-sensing infrared thermography: alarm temperature and optimal distance.
  Journal of the Formosan Medical Association 107(12), 937-44.
• Das, A, Spackman, E, Pantin-Jackwood, MJ and Suarez, DL. (2009),
  Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of Avian influenza virus by RT-PCR.
  Journal of Veterinary Diagnostic Investigation 21(6), 771-778.
• Department of Health and Human Services: Food and Drug Administration. (2009),
  Medical devices; immunology and microbiology devices; classification of respiratory viral panel multiplex nucleic acid assay. Final rule.
  Federal Register 74(195), 52136-8.
• Duplan, V, Miron, Y, Frost, E, Grandbois, M and Dubowski, JJ. (2009),
  Specific immobilization of influenza A virus on GaAs (001) surface.
  Journal of Biomedical Optics 14(5), 054042.
• Gardner, SN, Hiddessen, AL, Williams, PL, Hara, C, Wagner, MC and Colston, BW. (2009),
  Multiplex primer prediction software for divergent targets.
  Nucleic Acids Research 37(19), 6291-6304.
• Gu, B, Park, TJ, Ahn, JH, Huang, XJ, Lee, SY and Choi, YK. (2009),
  Nanogap field-effect transistor biosensors for electrical detection of avian influenza.
  Small 5(21), 2407-2412.
• Hewa, TMP, Tannock, GA, Mainwaring, DE, Harrison, S and Fecondo, JV. (2009),
  The detection of influenza A and B viruses in clinical specimens using a quartz crystal microbalance.
  Journal of Virological Methods 162(1-2), 14-21.
• Hoffmann, B, Beer, M, Reid, SM, Mertens, P, Oura, CAL, van Rijn, PA, Slomka, MJ, Banks, J, Brown, IH, Alexander, DJ and King, DP. (2009),
  A review of RT-PCR technologies used in veterinary virology and disease control: sensitive and specific diagnosis of five livestock diseases notifiable to the World Organisation for Animal Health.
  Veterinary Microbiology 139(1-2), 1-23.
• Lewandrowski, K. (2009),
  Selected topics in point-of-care testing: whole blood creatinine, influenza testing, fetal fibronectin and patient self-testing in the home.
  Clinics in Laboratory Medicine 29(3), 607-614.
• Li, XH, Qi, X, Miao, L, Wang, Y, Liu, FZ, Gu, HW, Lu, SW, Yang, YH and Liu, FY. (2009),
  Detection and subtyping of influenza A virus based on a short oligonucleotide microarray.
  Diagnostic Microbiology and Infectious Disease 65(3), 261-270.
• Lieberman, D, Shimoni, A, Keren-Naus, A, Steinberg, R and Shemer-Avni, Y. (2009),
  Identification of respiratory viruses in adults: nasopharyngeal versus oropharyngeal sampling.
  Journal of Clinical Microbiology 47(11), 3439-3443.
• Liu, S, Hou, GY, Zhuang, QY, Shu, YL, Chen, JM, Jiang, WM, Chen, J and Li, JP. (2009),
  A SYBR Green I real-time RT-PCR assay for detection and differentiation of influenza A(H1N1) virus in swine populations.
  Journal of Virological Methods 162(1-2), 184-187.
• Mintegi, S, Garcia-Garcia, JJ, Benito, J, Carrasco-Colom, J, Gomez, B, Hernandez-Bou, S, Astobiza, E and Luaces-Cubells, C. (2009),
  Rapid influenza test in young febrile infants for the identification of low-risk patients.
  Pediatric Infectious Disease Journal 28(11), 1026-1028.
• Nowak, JA and Kaul, KL. (2009),
  The role of community molecular diagnostics laboratories in the H1N1 pandemic.
  Journal of Molecular Diagnostics 11(5), 369-70.
• Pabbaraju, K, Wong, S, Wong, AA, Appleyard, GD, Chui, L, Pang, XL, Yanow, SK, Fonseca, K, Lee, BE, Fox, JD and Preiksaitis, JK. (2009),
  Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus.
  Journal of Clinical Microbiology 47(11), 3454-3460.
• Panning, M, Eickmann, M, Landt, O, Monazahian, M, Olschlager, S, Baumgarte, S, Reischl, U, Wenzel, JJ, Niller, HH, Gunther, S, Hollmann, B, Huzly, D, Drexler, JF, Helmer, A, Becker, S, Matz, B, Eis-Hubinger, AM and Drosten, C. (2009),
  Detection of influenza A(H1N1)v virus by real-time RT-PCR.
  Eurosurveillance 14(36), 7-12.
• Peacey, M, Hall, RJ, Bocacao, J and Huang, QS. (2009),
  Diagnostic assay recommended by the World Health Organization for swine origin influenza A (H1N1) virus cross-reacts with H5N1 influenza virus.
  Journal of Clinical Microbiology 47(11), 3789-3790.
• Rashid, S, Naeem, K, Ahmed, Z, Saddique, N, Abbas, MA and Malik, SA. (2009),
  Multiplex polymerase chain reaction for the detection and differentiation of avian influenza viruses and other poultry respiratory pathogens.
  Poultry Science 88(12), 2526-2531.
• Sails, AD, Saunders, D, Airs, S, Roberts, D, Eltringham, G and Magee, JG. (2009),
  Evaluation of the cepheid respiratory syncytial virus and influenza virus A/B real-time PCR analyte specific reagent.
  Journal of Virological Methods 162(1-2), 88-90.
• Schwahn, AB, Wong, JWH and Downard, KM. (2009),
  Signature peptides of influenza nucleoprotein for the typing and subtyping of the virus by high resolution mass spectrometry.
  Analyst 134(11), 2253-2261.
• Tam, PD, Hieu, VN, Chien, ND, Le, AT and Tuan, MA. (2009),
  DNA sensor development based on multi-wall carbon nanotubes for label-free influenza virus (type A) detection.
  Journal of Immunological Methods 350(1-2), 118-124.
• Upadhyay, C, Ammayappan, A and Vakharia, VN. (2009),
  Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens.
  Virology Journal 6, 158.
• Vasoo, S, Stevens, J and Singh, K. (2009),
  Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1.
  Clinical Infectious Diseases 49(7), 1090-3.
• Wang, W, Ren, P, Sheng, J, Mardy, S, Yan, H, Zhang, J, Hou, L, Vabret, A, Buchy, P, Freymuth, F and Deubel, V. (2009),
  Simultaneous detection of respiratory viruses in children with acute respiratory infection using two different multiplex reverse transcription-PCR assays.
  Journal of Virological Methods 162(1-2), 40-45.
• Yang, JR, Lo, J, Liu, JL, Lin, CH, Ho, YL, Chen, CJ, Wu, HS and Liu, MT. (2009),
  Rapid SYBR green I and modified probe real-time reverse transcription-PCR assays identify influenza H1N1 viruses and distinguish between pandemic and seasonal strains.
  Journal of Clinical Microbiology 47(11), 3714-3716.
• Yang, M, Clavijo, A, Grahama, J, Salo, T, Hole, K and Berhane, Y. (2009),
  Production and diagnostic application of monoclonal antibodies against influenza virus H5.
  Journal of Virological Methods 162(1-2), 194-202.

Back to top

Epidemiology

• Anonymous. (2009),
  Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009.
  Weekly Epidemiological Record 84(44), 453-9.
• Adeola, OA, Adeniji, JA and Olugasa, BO. (2009),
  Isolation of influenza A viruses from pigs in Ibadan, Nigeria.
  Veterinaria Italiana 45(3), 383-390.
• Altay, G, Ersoy, O, Wahab, MA, El Afandi, G, Shokr, M, El Ghazawi, T, Mohamed, MA, Eleithy, B, Abou El-Magd, I, Biehl, L, Grant, D, Rochon, G and Fall, S. (2009),
  Deployment of real-time satellite remote sensing infrastructure to support disaster mitigation: a NATO Science for Peace collaboration project with research universities in Turkey, Egypt and the USA.
  RAST 2009: Proceedings of the 4th International Conference on Recent Advances in Space Technologies, 18-22.
• Altschuler, EL, Kariuki, YM and Jobanputra, A. (2009),
  Extant blood samples to deduce the strains of the 1890 and possibly earlier pandemic influenzas.
  Medical Hypotheses 73(5), 846-848.
• Archer, BN, Cohen, C, Naidoo, D, Thomas, J, Makunga, C, Blumberg, L, Venter, M, Timothy, GA, Puren, A, McAnerney, JM, Cengimbo, A and Schoub, BD. (2009),
  Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases.
  Eurosurveillance 14(42), 11-15.
• Askling, HH, Lesko, B, Vene, S, Berndtson, A, Bjorkman, P, Blackberg, J, Bronner, U, Follin, P, Hellgren, U, Palmerus, M, Ekdahl, K, Tegnell, A and Struwe, J. (2009),
  Serologic analysis of returned travelers with fever, Sweden.
  Emerging Infectious Diseases 15(11), 1805-1808.
• Bacaer, N and Gomes, MGM. (2009),
  On the final size of epidemics with seasonality.
  Bulletin of Mathematical Biology 71(8), 1954-1966.
• Baker, MG, Wilson, N, Huang, QS, Paine, S, Lopez, L, Bandaranayake, D, Tobias, M, Mason, K, Mackereth, GF, Jacobs, M, Thornley, C, Roberts, S and McArthur, C. (2009),
  Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.
  Eurosurveillance 14(34), 6-11.
• Balint, A, Metreveli, G, Widen, F, Zohari, S, Berg, M, Isaksson, M, Renstrom, LHM, Wallgren, P, Belak, S, Segall, T and Kiss, I. (2009),
  The first Swedish H1N2 swine influenza virus isolate represents an uncommon reassortant.
  Virology Journal 6, 180.
• Brouwers, L, Cakici, B, Camitz, M, Tegnell, A and Boman, M. (2009),
  Economic consequences to society of pandemic H1N1 influenza 2009-preliminary results for Sweden.
  Eurosurveillance 14(37), 5-11.
• Burrel, S, Roncin, L, Lafon, ME and Fleury, H. (2009),
  Oseltamivir susceptibility in South-Western France during the 2007-8 and 2008-9 influenza epidemics and the ongoing influenza pandemic 2009.
  Eurosurveillance 14(38), 8-9.
• Cai, W, Schweiger, B, Buchholz, U, Buda, S, Littmann, M, Heusler, J and Haas, W. (2009),
  Protective measures and H5N1-seroprevalence among personnel tasked with bird collection during an outbreak of avian influenza A/H5N1 in wild birds, Ruegen, Germany, 2006.
  BMC Infectious Diseases 9, 170.
• Carneiro, HA and Mylonakis, E. (2009),
  Google Trends: a web-based tool for real-time surveillance of disease outbreaks.
  Clinical Infectious Diseases 49(10), 1557-1564.
• Centers for Disease Control and Prevention. (2009),
  Update: influenza activity - United States, August 30-October 31, 2009.
  MMWR - Morbidity & Mortality Weekly Report 58(44), 1236-41.
• Chen, K-F, Gaydos, C and Rothman, RE. (2009),
  Hospitalized patients with novel influenza A (H1N1) virus infection--California, April-May, 2009.
  Annals of Emergency Medicine 54(5), 732-6.
• Choi, WY, Kim, S, Lee, N, Kwon, M, Yang, I, Kim, MJ, Cheong, SG, Kwon, D, Lee, JY, Oh, HB and Kang, C. (2009),
  Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
  Antiviral Research 84(2), 199-202.
• Ciblak, MA, Albayrak, N, Odabas, Y, Altas, AB, Kanturvardar, M, Hasoksuz, M, Sucakli, B, Korukluoglu, G, Bal, E, Ertek, M and Badur, S. (2009),
  Cases of influenza A(H1N1)v reported in Turkey, May-July 2009.
  Eurosurveillance 14(32), 2-5.
• Cowled, B, Ward, MP, Hamilton, S and Garner, G. (2009),
  The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic.
  Preventive Veterinary Medicine 92(1-2), 60-70.
• Dapat, C, Saito, R, Kyaw, Y, Naito, M, Hasegawa, G, Suzuki, Y, Dapat, IC, Zaraket, H, Cho, TM, Li, DJ, Oguma, T, Baranovich, T and Suzuki, H. (2009),
  Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007.
  Intervirology 52(6), 310-320.
• Daugherty, EL, Perl, TM, Rubinson, L, Bilderback, A and Rand, CS. (2009),
  Survey study of the knowledge, attitudes, and expected behaviors of critical care clinicians regarding an influenza pandemic.
  Infection Control and Hospital Epidemiology 30(12), 1143-1149.
• De Vleeschauwer, A, Van Poucke, S, Braeckmans, D, Van Doorsselaere, J and Van Reeth, K. (2009),
  Efficient transmission of swine-adapted but not wholly avian influenza viruses among pigs and from pigs to ferrets.
  Journal of Infectious Diseases 200(12), 1884-1892.
• Dominguez-Cherit, G, Lapinsky, SE, Macias, AE, Pinto, R, Espinosa-Perez, L, de la Torre, A, Poblano-Morales, M, Baltazar-Torres, JA, Bautista, E, Martinez, A, Martinez, MA, Rivero, E, Valdez, R, Ruiz-Palacios, G, Hernandez, M, Stewart, TE and Fowler, RA. (2009),
  Critically ill patients with 2009 influenza A(H1N1) in Mexico.
  JAMA-Journal of the American Medical Association 302(17), 1880-1887.
• Furuse, Y, Suzuki, A, Shimizu, M, Kishi, M, Sawayama, R, Saito, M, Fuji, N, Nukiwa, N and Oshitani, H. (2009),
  Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season.
  Journal of Infectious Diseases 200(11), 1766-1773.
• Gianella, A, Walter, A, Revollo, R, Loayza, R, Vargas, J and Roca, Y. (2009),
  Epidemiological analysis of the influenza A(H1N1)v outbreak in Bolivia, May-August 2009.
  Eurosurveillance 14(35), 7-10.
• Gilsdorf, A and Poggensee, G. (2009),
  Influenza A(H1N1)v in Germany: the first 10,000 cases.
  Eurosurveillance 14(34), 2-5.
• Goodwin, R, Haque, S, Neto, F and Myers, LB. (2009),
  Initial psychological responses to Influenza A, H1N1 ("Swine flu").
  BMC Infectious Diseases 9, 166.
• Hegyi, G, Moller, AP, Eens, M and Garamszegi, LZ. (2009),
  Prevalence of avian influenza and sexual selection in ducks.
  Behavioral Ecology 20(6), 1289-1294.
• Higa, F, Naka, M, Tateyama, M, Haranaga, S, Yara, S, Koide, M, Yamane, N and Fujita, J. (2009),
  Epidemiology of influenza from 2007 to 2008 in Naha area, Okinawa Prefecture: surveillance of rapid antigen test results.
  Japanese Journal of Infectious Diseases 62(5), 399-401.
• Howden, KJ, Brockhoff, EJ, Caya, FD, McLeod, LJ, Lavoie, M, Ing, JD, Bystrom, JM, Alexandersen, S, Pasick, JM, Berhane, Y, Morrison, ME, Keenliside, JM, Laurendeau, S and Rohonczy, EB. (2009),
  An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm.
  Canadian Veterinary Journal-Revue Veterinaire Canadienne 50(11), 1153-1161.
• Jackson, G and Thornley, S. (2009),
  Burden of novel influenza A virus (H1N1) in Auckland and Counties Manukau District Heath Boards (July 2009): a capture-recapture analysis.
  New Zealand Medical Journal 122(1301), 66-9.
• Jahangir, A, Ruenphet, S, Shoham, D, Okamura, M, Nakamaura, M and Takehara, K. (2009),
  Phenotypic, genetic, and phylogeographical characterization of avian influenza virus subtype H5N2 isolated from northern pintail (Anas acuta) in Japan.
  Virus Research 145(2), 329-333.
• Kar-Purkayastha, I, Ingram, C, Maguire, H and Roche, A. (2009),
  The importance of school and social activities in the transmission of influenza A(H1N1)v: England, April-June 2009.
  Eurosurveillance 14(33), 8-11.
• Koliou, M, Soteriades, ES, Toumasi, MM, Demosthenous, A and Hadjidemetriou, A. (2009),
  Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June-August 2009.
  Eurosurveillance 14(33), 12-14.
• Kretzschmar, M and Mikolajczyk, RT. (2009),
  Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases.
  PLoS ONE 4(6), e5931.
• Kumar, A, Zarychanski, R, Pinto, R, Cook, DJ, Marshall, J, Lacroix, J, Stelfox, T, Bagshaw, S, Choong, K, Lamontagne, F, Turgeon, AF, Lapinsky, S, Ahern, SP, Smith, O, Siddiqui, F, Jouvet, P, Khwaja, K, McIntyre, L, Menon, K, Hutchison, J, Hornstein, D, Joffe, A, Lauzier, F, Singh, J, Karachi, T, Wiebe, K, Olafson, K, Ramsey, C, Sharma, S, Dodek, P, Meade, M, Hall, R and Fowler, RA. (2009),
  Critically ill patients with 2009 influenza A(H1N1) infection in Canada.
  JAMA-Journal of the American Medical Association 302(17), 1872-1879.
• La Ruche, G, Tarantola, A, Barboza, P, Vaillant, L, Gueguen, J and Gastellu-Etchegorry, M. (2009),
  The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific.
  Eurosurveillance 14(42), 51-56.
• Laguna-Torres, VA, Gomez, J, Ocana, V, Aguilar, P, Saldarriaga, T, Chavez, E, Perez, J, Zamalloa, H, Forshey, B, Paz, I, Gomez, E, Ore, R, Chauca, G, Ortiz, E, Villaran, M, Vilcarromero, S, Rocha, C, Chincha, O, Jimenez, G, Villanueva, M, Pozo, E, Aspajo, J and Kochel, T. (2009),
  Influenza-like illness sentinel surveillance in Peru.
  PLoS ONE 4(7), e6118.
• Leibler, JH, Otte, J, Roland-Holst, D, Pfeiffer, DU, Magalhaes, RS, Rushton, J, Graham, JP and Silbergeld, EK. (2009),
  Industrial food animal production and global health risks: exploring the ecosystems and economics of avian influenza.
  Ecohealth 6(1), 58-70.
• Lemey, P, Rambaut, A, Drummond, AJ and Suchard, MA. (2009),
  Bayesian phylogeography finds its roots.
  PLoS Computational Biology 5(9), e1000520.
• Linde, A, Rotzen-Ostlund, M, Zweygberg-Wirgart, B, Rubinova, S and Brytting, M. (2009),
  Does viral interference affect spread of influenza?
  Eurosurveillance 14(40), 2-4.
• Lu, J, Liu, DB, Liu, W, Shi, TX, Tong, YG and Cao, WC. (2009),
  Genetic stability and linkage analysis of the 2009 influenza A(H1N1) virus based on sequence homology.
  Archives of Virology 154(12), 1883-1890.
• Lv, X-H, Jiang, C-Y and Zhou, Y-B. (2009),
  [Serological survey on antibodies to influenza A viruses subtype H1, H3, H5 and H9 of population in Shanghai].
  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology 30(3), 302.
• Mardy, S, Ly, S, Heng, S, Vong, S, Huch, C, Nora, C, Asgari, N, Miller, M, Bergeri, I, Rehmet, S, Veasna, D, Zhou, W, Kasai, T, Touch, S and Buchy, P. (2009),
  Influenza activity in Cambodia during 2006-2008.
  BMC Infectious Diseases 9, 168.
• Martin, J, O'Donnell, J, Igoe, D, O'Hora, A, Thornton, L, Murphy, N, Cullen, G, Fitzgerald, M, Cotter, S, McKeown, P and O'Flanagan, D. (2009),
  Enhanced surveillance of initial cases of pandemic H1N1 2009 influenza in Ireland, April-July 2009.
  Eurosurveillance 14(38), 3-7.
• McBryde, ES, Bergeri, I, van Gemert, C, Rotty, J, Headley, EJ, Simpson, K, Lester, RA, Hellard, M and Fielding, JE. (2009),
  Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May-3 June 2009.
  Eurosurveillance 14(42), 45-50.
• Melidou, A, Exindari, M, Gioula, G, Chatzidimitriou, D, Pierroutsakos, Y and Diza-Mataftsi, E. (2009),
  Molecular and phylogenetic analysis and vaccine strain match of human influenza A(H3N2) viruses isolated in Northern Greece between 2004 and 2008.
  Virus Research 145(2), 220-226.
• Merl, D, Johnson, LR, Gramacy, RB and Mangel, M. (2009),
  A statistical framework for the adaptive management of epidemiological interventions.
  PLoS ONE 4(6), e5807.
• Munayco, CV, Gomez, J, Laguna-Torres, VA, Arrasco, J, Kochel, TJ, Fiestas, V, Garcia, J, Perez, J, Torres, I, Condori, F, Nishiura, H and Chowell, G. (2009),
  Epidemiological and transmissibility analysis of influenza A(H1N1)v in a Southern Hemisphere setting: Peru.
  Eurosurveillance 14(32), 6-10.
• Munster, VJ and Fouchier, RAM. (2008),
  Avian influenza virus: of virus and bird ecology.
  Vaccine 27(45), 6340-6344.
• Nau, J-Y. (2009),
  [The shadow of the influenza A (H1N1) in Mecca].
  Revue Medicale Suisse 5(214), 1684.
• Nicoll, A and Coulombier, D. (2009),
  Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices.
  Eurosurveillance 14(29), 18-23.
• Odaira, F, Takahashi, H, Toyokawa, T, Tsuchihashi, Y, Kodama, T, Yahata, Y, Sunagawa, T, Taniguchi, K and Okabe, N. (2009),
  Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May- June 2009.
  Eurosurveillance 14(35), 2-6.
• Park, AW, Daly, JM, Lewis, NS, Smith, DJ, Wood, JLN and Grenfell, BT. (2009),
  Quantifying the impact of immune escape on transmission dynamics of influenza.
  Science 326(5953), 726-728.
• Pearce, JM, Ramey, AM, Flint, PL, Koehler, AV, Fleskes, JP, Franson, JC, Hall, JS, Derksen, DV and Ip, HS. (2009),
  Avian influenza at both ends of a migratory flyway: characterizing viral genomic diversity to optimize surveillance plans for North America.
  Evolutionary Applications 2(4), 457-468.
• Peng, D, Zhao, DC, Liu, JT, Wang, X, Yang, K, Xicheng, H, Li, Y and Wang, FB. (2009),
  Multipathogen infections in hospitalized children with acute respiratory infections.
  Virology Journal 6, 155.
• Peng, SL, Tsay, YW, Lin, CS and Tang, CY. (2009),
  CAPS genomic subtyping on Orthomyxoviridae.
  Emerging intelligent computing technology and applications 5754, 130-137.
• Polgreen, PM, Chen, Z, Segre, AM, Harris, ML, Pentella, MA and Rushton, G. (2009),
  Optimizing influenza sentinel surveillance at the state level.
  American Journal of Epidemiology 170(10), 1300-6.
• Riviera, J and Li, Y. (2010),
  Existence of traveling wave solutions for a nonlocal reaction-diffusion model of influenza a drift.
  Discrete and Continuous Dynamical Systems-Series B 13(1), 157-174.
• Rodriguez, CV, Rietberg, K, Baer, A, Kwan-Gett, T and Duchin, J. (2009),
  Association between school closure and subsequent absenteeism during a seasonal influenza epidemic.
  Epidemiology 20(6), 787-792.
• Romanowska, M, Czarkowski, MP, Nowak, I and Brydak, LB. (2009),
  [Influenza in Poland in 2007].
  Przeglad Epidemiologiczny 63(2), 185-9.
• Schout, D, Hajjar, LA, Galas, F, Uip, DE, Levin, ASS, Caiaffa, HH, Sakane, PT, Suslik, CA, Teixeira, JMD, Bonfa, E, Barone, AA, Martins, MD, Boulos, M and Auler, JOC. (2009),
  Epidemiology of human infection with the novel virus influenza A (H1N1) in the Hospital Das Clinicas, Sao Paulo, Brazil - June-September 2009.
  Clinics 64(10), 1025-1030.
• Sedlmaier, N, Hoppenheidt, K, Krist, H, Lehmann, S, Lang, H and Buttner, M. (2009),
  Generation of avian influenza virus (AIV) contaminated fecal fine particulate matter (PM2.5): genome and infectivity detection and calculation of immission.
  Veterinary Microbiology 139(1-2), 156-164.
• Socan, M, Trilar, KP, Berginc, N and Frelih, T. (2009),
  Epidemiological and clinical features of patients infected with influenza A(H1N1)v in Slovenia.
  Zdravniski Vestnik-Slovenian Medical Journal 78(9), 467-472.
• Suwannakarn, K, Amonsin, A, Sasipreeyajan, J, Kitikoon, P, Tantilertcharoen, R, Parchariyanon, S, Chaisingh, A, Nuansrichay, B, Songserm, T, Theamboonlers, A and Poovorawan, Y. (2009),
  Molecular evolution of H5N1 in Thailand between 2004 and 2008.
  Infection, Genetics & Evolution 9(5), 896-902.
• Szeleczky, Z, Dan, A, Ursu, K, Ivanics, E, Kiss, I, Erdelyi, K, Belak, S, Muller, CP, Brown, IH and Balint, A. (2009),
  Four different sublineages of highly pathogenic avian influenza H5N1 introduced in Hungary in 2006-2007.
  Veterinary Microbiology 139(1-2), 24-33.
• Terregino, C, De Nardi, R, Nisi, R, Cilloni, F, Salviato, A, Fasolato, M and Capua, I. (2009),
  Resistance of turkeys to experimental infection with an early 2009 Italian human influenza A(H1N1)v virus isolate.
  Eurosurveillance 14(41), 9-11.
• Thouillot, F, Do, C, Balleydier, E, Rachou, E, Staikowsky, F, Morbidelli, P, Jacques-Antoine, Y, Bourde, A, Lagrange-Xelot, M, Poubeau, P, Winer, A, Gauzere, BA, Michault, A, Jaffar-Bandjee, MC, Henrion, G, Filleul, L and D'Ortenzio, E. (2009),
  Preliminary analysis of the pandemic H1N1 influenza on Reunion Island (Indian Ocean): surveillance trends (July to Mid-September 2009).
  Eurosurveillance 14(42), 7-10.
• Towers, S and Feng, Z. (2009),
  Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States.
  Eurosurveillance 14(41), 6-8.
• Uphoff, H, Geis, S, Gruber, A and Hauri, AM. (2009),
  What will the next influenza season bring about: seasonal influenza or the new A(H1N1)v? An analysis of German influenza surveillance data.
  Eurosurveillance 14(32), 11-13.
• Usui, T, Yamaguchi, T, Ito, H, Ozaki, H, Murase, T and Ito, T. (2009),
  Evolutionary genetics of highly pathogenic H5N1 avian influenza viruses isolated from whooper swans in northern Japan in 2008.
  Virus Genes 39(3), 319-323.
• Vaillant, L, La Ruche, G, Tarantola, A and Barboza, P. (2009),
  Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.
  Eurosurveillance 14(33), 2-7.
• Van Kerkhove, MD, Vong, S, Guitian, J, Holl, D, Mangtani, P, San, S and Ghani, AC. (2008),
  Poultry movement networks in Cambodia: implications for surveillance and control of highly pathogenic avian influenza (HPAI/H5N1).
  Vaccine 27(45), 6345-6352.
• Wan, X-F, Nguyen, T, Davis, CT, Smith, CB, Zhao, Z-M, Carrel, M, Inui, K, Do, HT, Mai, DT, Jadhao, S, Balish, A, Shu, B, Luo, F, Emch, M, Matsuoka, Y, Lindstrom, SE, Cox, NJ, Nguyen, CV, Klimov, A and Donis, RO. (2008),
  Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007.
  PLoS ONE 3(10), e3462.
• White, LF, Wallinga, J, Finelli, L, Reed, C, Riley, S, Lipsitch, M and Pagano, M. (2009),
  Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA.
  Influenza and Other Respiratory Viruses 3(6), 267-276.
• Yamanaka, T, Nemoto, M, Tsujimura, K, Kondo, T and Matsumura, T. (2009),
  Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses.
  Veterinary Microbiology 139(3-4), 351-355.
• Yang, Y, Sugimoto, JD, Halloran, ME, Basta, NE, Chao, DL, Matrajt, L, Potter, G, Kenah, E and Longini, IM. (2009),
  The transmissibility and control of pandemic influenza A (H1N1) virus.
  Science 326(5953), 729-733.
• Yassine, HM, Khatri, M, Zhang, YJ, Lee, CW, Byrum, BA, O'Quin, J, Smith, KA and Saif, YM. (2009),
  Characterization of triple reassortant H1N1 influenza A viruses from swine in Ohio.
  Veterinary Microbiology 139(1-2), 132-139.
• Yee, KS, Carpenter, TE, Farver, TB and Cardona, CJ. (2009),
  An evaluation of transmission routes for low pathogenicity avian influenza virus among chickens sold in live bird markets.
  Virology 394(1), 19-27.
• Zhang, S-X, Cheng, J-Q, Ma, H-W, He, J-F, Cheng, X-W, Jiang, L-J, Mou, J, Wu, C-L, Lv, X, Zhang, S-H, Zhang, Y-D, Wu, Y-S and Wang, X. (2008),
  [A case of human highly pathogenic avian influenza in Shenzhen, China: application of field epidemiological study].
  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology 29(3), 248-52.

Back to top

Immunology and immunity

• Crowe, CR, Chen, K, Pociask, DA, Alcorn, JF, Krivich, C, Enelow, RI, Ross, TM, Witztum, JL and Kolls, JK. (2009),
  Critical role of IL-17RA in immunopathology of influenza infection.
  Journal of Immunology 183(8), 5301-5310.
• Cusick, MF, Wang, SP and Eckels, DD. (2009),
  In vitro responses to avian influenza H5 by human CD4 T cells.
  Journal of Immunology 183(10), 6432-6441.
• El Mchichi, B, Dianoux, L and Chelbi-Alix, MK. (2008),
  RNA viral infections: role and fate of PML.
  Proceedings of the 7th Joint Meeting of the International Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research , 27-31.
• GeurtsvanKessel, CH, Willart, MAM, Bergen, IM, van Rijt, LS, Muskens, F, Elewaut, D, Osterhaus, A, Hendriks, R, Rimmelzwaan, GF and Lambrecht, BN. (2009),
  Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice.
  Journal of Experimental Medicine 206(11), 2339-2349.
• Greenbaum, BD, Rabadan, R and Levine, AJ. (2009),
  Patterns of oligonucleotide sequences in viral and host cell RNA identify mediators of the host innate immune system.
  PLoS ONE 4(6), e5969.
• Hancock, K, Veguilla, V, Lu, XH, Zhong, WM, Butler, EN, Sun, H, Liu, F, Dong, LB, DeVos, JR, Gargiullo, PM, Brammer, TL, Cox, NJ, Tumpey, TM and Katz, JM. (2009),
  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
  New England Journal of Medicine 361(20), 1945-1952.
• Ning, ZY, Luo, MY, Qi, WB, Yu, B, Jiao, PR and Liao, M. (2009),
  Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry.
  Veterinary Research Communications 33(8), 895-903.
• Patel, JA, Nair, S, Revai, K, Grady, J and Chonmaitree, T. (2009),
  Nasopharyngeal acute phase cytokines in viral upper respiratory infection impact on acute otitis media in children.
  Pediatric Infectious Disease Journal 28(11), 1002-1007.
• Pei, SB, Xiong, N, Zhang, Y and Chen, SY. (2009),
  Increasing M2 epitope density enhances systemic and mucosal immune responses to influenza A virus.
  Biotechnology Letters 31(12), 1851-1856.
• Perez-Trallero, E, Pineiro, L, Vicente, D, Montes, M and Cilla, G. (2009),
  Residual immunity in older people against the influenza A(H1N1) - recent experience in Northern Spain.
  Eurosurveillance 14(39), 2-4.
• Powe, JR and Castleman, WL. (2009),
  Canine influenza virus replicates in alveolar macrophages and induces TNF-α.
  Veterinary Pathology 46(6), 1187-1196.
• Rimmelzwaan, GF, Kreijtz, J, Bodewes, R, Fouchier, RAM and Osterhaus, A. (2008),
  Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
  Vaccine 27(45), 6363-6365.
• Sawabuchi, T, Suzuki, S, Iwase, K, Ito, C, Mizuno, D, Togari, H, Watanabe, I, Talukder, SR, Chida, J and Kido, H. (2009),
  Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza.
  Respirology 14(8), 1173-1179.
• Schmolke, M, Viemann, D, Roth, J and Ludwig, S. (2009),
  Essential impact of NF-κ B signaling on the H5N1 influenza A virus-induced transcriptome.
  Journal of Immunology 183(8), 5180-5189.
• Tam, AHM, Lee, DCW, Law, AHY, Peiris, M and Lau, ASY. (2008),
  Regulation of avian influenza H9N2/G1 virus-activated p38 MAPK by cellular phosphatases.
  Proceedings of the 7th Joint Meeting of the International Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research , 99-103.
• Van Reeth, K, Braeckmans, D, Cox, E, Van Borm, S, van den Berg, T, Goddeeris, B and De Vleeschauwer, A. (2008),
  Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
  Vaccine 27(45), 6330-6339.
• Wang, CC, Chen, JR, Tseng, YC, Hsu, CH, Hung, YF, Chen, SW, Chen, CM, Khoo, KH, Cheng, TJ, Cheng, YSE, Jan, JT, Wu, CY, Ma, C and Wong, CH. (2009),
  Glycans on influenza hemagglutinin affect receptor binding and immune response.
  Proceedings of the National Academy of Sciences of the United States of America 106(43), 18137-18142.
• Xie, DX, Bai, H, Liu, LH, Xie, XY, Ayello, J, Ma, XH and Zhang, JY. (2009),
  Apoptosis of lymphocytes and monocytes infected with influenza virus might be the mechanism of combating virus and causing secondary infection by influenza.
  International Immunology 21(11), 1251-1262.
• Yang, M. (2009),
  MAbs against influenza virus H7 subtype.
  Hybridoma 28(5), 387.

Back to top

Pandemics - planning and threats

• Adini, B, Goldberg, A, Cohen, R and Bar-Dayan, Y. (2009),
  Relationship between equipment and infrastructure for pandemic influenza and performance in an avian flu drill.
  Emergency Medicine Journal 26(11), 786-790.
• Barnett, DJ, Balicer, RD, Thompson, CB, Storey, JD, Omer, SB, Semon, NL, Bayer, S, Cheek, LV, Gateley, KW, Lanza, KM, Norbin, JA, Slemp, CC and Links, JM. (2009),
  Assessment of local public health workers' willingness to respond to pandemic influenza through application of the extended parallel process model.
  PLoS ONE 4(7), e6365.
• Cavanagh, M. (2009),
  A pandemic is not a game--and here's a game to prove it.
  Health Progress 90(5), 53-5.
• Chakraborti, C. (2009),
  Pandemic management and developing world bioethics: bird flu in West Bengal.
  Developing World Bioethics 9(3), 161-166.
• Courtney, B. (2009),
  FDA Emergency Use Authorizations (EUAs): what are they and what do they mean for the H1N1 swine flu response?
  Biosecurity & Bioterrorism 7(2), 211-20.
• Cowie, BC. (2009),
  A pandemic problem with public transport.
  Medical Journal of Australia 191(5), 288-9.
• Eichner, M, Schwehm, M, Wilson, N and Baker, MG. (2009),
  Small islands and pandemic influenza: potential benefits and limitations of travel volume reduction as a border control measure.
  BMC Infectious Diseases 9, 160.
• Flyborg, C and Donati, D. (2009),
  Pandemic preparedness: what more can we do?
  Biopharm International (Suppl.), 4.
• Franco-Giraldo, A and Alvarez-Dardet, C. (2009),
  [Global public health: international health is tested to its limits by the human influenza A epidemic].
  Pan American Journal of Public Health 25(6), 540-7.
• Khanna, M and Gupta, N. (2009),
  Influenza A (H1N1) pandemic: preparedness and clinical management.
  Indian Journal of Experimental Biology 47(11), 929-932.
• Kimball, AM, Arima, Y, French, HM, Osaki, CS, Hoff, R, Lee, SS, Schafer, L, Nabae, K, Hsun, C, Hishamuddin, P, Nelson, R, Woody, K, Brown, J and Fox, L. (2009),
  Pandemic influenza planning by videoconference.
  Journal of Telemedicine and Telecare 15(7), 368-372.
• Lee, P. (2009),
  Evaluating the effectiveness of swine flu contingency policies in healthcare education.
  Nursing Times 105(35), 20-2.
• Mastroianni, AC. (2009),
  Slipping through the net: social vulnerability in pandemic planning.
  Hastings Center Report 39(5), 11-2.
• Nori, A and Williams, MA. (2009),
  Pandemic preparedness risk management and infection control for all respiratory infection outbreaks.
  Australian Family Physician 38(11), 891-895.
• Pratt, RJ. (2009),
  The global swine flu pandemic 1: exploring the background to influenza viruses.
  Nursing Times 105(34), 18-21.
• Pratt, RJ. (2009),
  The global swine flu pandemic 2: infection control measures and preparedness strategies.
  Nursing Times 105(35), 16-8.
• Sasaki, A, Hoen, AG, Ozonoff, A, Suzuki, H, Tanabe, N, Seki, N, Saito, R and Brownstein, JS. (2009),
  Evidence-based tool for triggering school closures during influenza outbreaks, Japan.
  Emerging Infectious Diseases 15(11), 1841-1843.
• Stern, AM, Cetron, MS and Markel, H. (2009),
  Closing the schools: lessons from the 1918-19 US influenza pandemic.
  Health Affairs 28(6), W1066-W1078.
• Webb, SAR, Pettila, V, Seppelt, I, Bellomo, R, Bailey, M, Cooper, DJ, Cretikos, M, Davies, AR, Finfer, S, Harrigan, PWJ, Hart, GK, Howe, B, Iredell, JR, McArthur, C, Mitchell, I, Morrison, S, Nichol, AD, Paterson, DL, Peake, S, Richards, B, Stephens, D, Turner, A and Yung, M. (2009),
  Critical care services and 2009 H1N1 influenza in Australia and New Zealand.
  New England Journal of Medicine 361(20), 1925-1934.
• Wilson, N, Summers, J, Baker, M and Rice, G. (2009),
  A bizarre case of drowning as a result of pandemic influenza (1918 pandemic).
  New Zealand Medical Journal 122(1302), 92-4.

Back to top

Structure, function and genetics

• Collins, PJ, Haire, LF, Lin, YP, Liu, J, Russell, RJ, Walker, PA, Martin, SR, Daniels, RS, Gregory, V, Skehel, JJ, Gamblin, SJ and Hay, AJ. (2008),
  Structural basis for oseltamivir resistance of influenza viruses.
  Vaccine 27(45), 6317-6323.
• Deyde, V, Garten, R, Sheu, T, Smith, C, Myrick, A, Barnes, J, Xu, XY, Shaw, M, Klimov, A and Gubareva, L. (2009),
  Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.
  Influenza and Other Respiratory Viruses 3(6), 297-314.
• Ding, N, Wu, NN, Xu, QG, Chen, KP and Zhang, CY. (2009),
  Molecular evolution of novel swine-origin A/H1N1 influenza viruses among and before human.
  Virus Genes 39(3), 293-300.
• dos Reis, M, Hay, AJ and Goldstein, RA. (2009),
  Using non-homogeneous models of nucleotide substitution to identify host shift events: application to the origin of the 1918 'Spanish' influenza pandemic virus.
  Journal of Molecular Evolution 69(4), 333-345.
• Gannage, M, Dormann, D, Albrecht, R, Dengjel, J, Torossi, T, Ramer, PC, Lee, M, Strowig, T, Arrey, F, Conenello, G, Pypaert, M, Andersen, J, Garcia-Sastre, A and Munz, C. (2009),
  Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.
  Cell Host & Microbe 6(4), 367-380.
• Hensley, SE, Das, SR, Bailey, AL, Schmidt, LM, Hickman, HD, Jayaraman, A, Viswanathan, K, Raman, R, Sasisekharan, R, Bennink, JR and Yewdell, JW. (2009),
  Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.
  Science 326(5953), 734-736.
• Hutchinson, EC, Wise, HM, Kudryavtseva, K, Curran, MD and Digard, P. (2008),
  Characterisation of influenza A viruses with mutations in segment S packaging signals.
  Vaccine 27(45), 6270-6275.
• Lazrak, A, Iles, KE, Liu, G, Noah, DL, Noah, JW and Matalon, S. (2009),
  Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species.
  FASEB Journal 23(11), 3829-3842.
• Li, Y, Guan, Z and Yan, J. (2009),
  [Screening cellular proteins interacted with M2 protein of influenza A virus by coimmunoprecipitation].
  Wei Sheng Wu Hsueh Pao - Acta Microbiologica Sinica 49(8), 1081-5.
• Lou, B, Zhu, X, Sun, B and Cui, Z. (2009),
  [Mutations of the hemagglutinin gene of H9N2 subtype avian influenza viruses under selective pressure of antibody].
  Wei Sheng Wu Hsueh Pao - Acta Microbiologica Sinica 49(7), 955-9.
• Loucaides, EM, von Kirchbach, JC, Foeglein, A, Sharps, J, Fodor, E and Digard, P. (2009),
  Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies.
  Virology 394(1), 154-163.
• Mernoli, MJ, Tumpey, TM, Jagger, BW, Dugan, VG, Sheng, ZM, Qi, L, Kash, JC and Taubenberger, JK. (2009),
  An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice.
  Virology 393(2), 338-345.
• Rouse, SL, Carpenter, T, Stansfeld, PJ and Sansom, MSP. (2009),
  Simulations of the BM2 proton channel transmembrane domain from influenza virus B.
  Biochemistry 48(42), 9949-9951.
• Schneider, J and Wolff, T. (2008),
  Nuclear functions of the influenza A and B viruses NS1 proteins: do they play a role in viral mRNA export?
  Vaccine 27(45), 6312-6316.
• Shishkov, AV, Bogacheva, EN, Dolgov, AA, Chulichkov, AL, Knyazev, DG, Fedorova, NV, Ksenofontov, AL, Kordyukova, LV, Lukashina, EV, Mirsky, VM and Baratova, LA. (2009),
  The in situ structural characterization of the influenza A virus matrix M1 protein within a virion.
  Protein and Peptide Letters 16(11), 1407-1413.
• Song, MS, Pascua, PNQ, Lee, JH, Baek, YH, Lee, OJ, Kim, CJ, Kim, H, Webby, RJ, Webster, RG and Choi, YK. (2009),
  The polymerase acidic protein gene of influenza A virus contributes to pathogenicity in a mouse model.
  Journal of Virology 83(23), 12325-12335.
• Takahashi, T, Hashimoto, A, Maruyama, M, Ishida, H, Kiso, M, Kawaoka, Y, Suzuki, Y and Suzuki, T. (2009),
  Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid.
  FEBS Letters 583(19), 3171-4.
• Tumpey, TM and Belser, JA. (2009),
  Resurrected pandemic influenza viruses.
  Annual Review of Microbiology 63, 79-98.
• Wanasawaeng, W, Bunpapong, N, Leelamanit, W and Thanawongnuwech, R. (2009),
  Growth characteristics of the H5N1 avian influenza virus in chicken embryonic eggs and MDCK cells.
  Thai Journal of Veterinary Medicine 39(3), 281-286.
• Wiwanitkit, V. (2009),
  Structural aberration in HA associated with adaptation of human influenza A H3N2 virus in embryonated chicken eggs.
  Turkish Journal of Veterinary & Animal Sciences 33(5), 437-438.
• Yamashita, M. (2009),
  [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
  Tanpakushitsu Kakusan Koso - Protein, Nucleic Acid, Enzyme 54(10), 1284-91.
• Yang, W, Qu, SP, Liu, QZ and Zheng, CY. (2009),
  Avian influenza virus A/chicken/Hubei/489/2004 (H5N1) induces caspase-dependent apoptosis in a cell-specific manner.
  Molecular and Cellular Biochemistry 332(1-2), 233-241.
• Zhang, JJ, Li, G, Liu, XL, Wang, ZF, Liu, WJ and Ye, X. (2009),
  Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA.
  Journal of General Virology 90(Part 11), 2751-2758.
• Zhirnov, OP and Klenk, HD. (2008),
  Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
  Virology 394(1), 57-63.

Back to top

Therapies and antivirals

• Abrahamyan, A, Nagy, E and Golovan, SP. (2009),
  Human H1 promoter expressed short hairpin RNAs (shRNAs) suppress avian influenza virus replication in chicken CH-SAH and canine MDCK cells.
  Antiviral Research 84(2), 159-167.
• Bing, FH, Liu, J, Li, Z, Zhang, GB, Liao, YF, Li, J and Dong, CY. (2009),
  Anti-influenza-virus activity of total alkaloids from Commelina communis L.
  Archives of Virology 154(11), 1837-1840.
• Garozzo, A, Timpanaro, R, Bisignano, B, Furneri, PM, Bisignano, G and Castro, A. (2009),
  In vitro antiviral activity of Melaleuca alternifolia essential oil.
  Letters in Applied Microbiology 49(6), 806-808.
• Gong, JZ, Fang, H, Li, MY, Liu, Y, Yang, KH, Liu, YZ and Xu, WF. (2009),
  Potential targets and their relevant inhibitors in anti-influenza fields.
  Current Medicinal Chemistry 16(28), 3716-3739.
• Gong, JZ, Liu, Y and Xu, WF. (2009),
  Pharmacophore model of influenza neuraminidase inhibitors - a systematic review.
  Pharmazie 64(10), 627-632.
• Greener, M. (2009),
  Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
  Nursing Times 105(34), 22.
• Griffith, R and Tengnah, C. (2009),
  The swine flu, advice giving and the reporting of adverse drug reactions.
  British Journal of Community Nursing 14(9), 405-9.
• Hanshaoworakul, W, Simmerman, JM, Narueponjirakul, U, Sanasuttipun, W, Shinde, V, Kaewchana, S, Areechokechai, D, Levy, J and Ungchusak, K. (2009),
  Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome.
  PLoS ONE 4(6), e6051.
• Hoffmann, G, Funk, C, Fowler, S, Otteneder, MB, Breidenbach, A, Rayner, CR, Chu, T and Prinssen, EP. (2009),
  Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.
  Antimicrobial Agents and Chemotherapy 53(11), 4753-4761.
• Honda, T and Masuda, T. (2009),
  Synthesis of 4-guanidino-7-modified-Neu5Ac2en derivatives and their biological activities as influenza sialidase inhibitors.
  Journal of Synthetic Organic Chemistry Japan 67(11), 1105-1114.
• Koudstaal, W, Koldijk, MH, Brakenhoff, JPJ, Cornelissen, L, Weverling, GJ, Friesen, RHE and Goudsmit, J. (2009),
  Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.
  Journal of Infectious Diseases 200(12), 1870-1873.
• Koyama, K, Takahashi, M, Oitate, M, Nakai, N, Takakusa, H, Miura, S and Okazaki, O. (2009),
  CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract.
  Antimicrobial Agents and Chemotherapy 53(11), 4845-4851.
• Lee, BY, Bailey, RR, Wiringa, AE, Assi, TM and Beigi, RH. (2009),
  Antiviral medications for pregnant women for pandemic and seasonal influenza an economic computer model.
  Obstetrics and Gynecology 114(5), 971-980.
• Li, Y, Zhou, BC and Wang, RX. (2009),
  Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1.
  Journal of Molecular Graphics & Modelling 28(3), 203-219.
• Liu, Z, Guo, ZM, Wang, GL, Zhang, DM, He, HX, Li, GW, Liu, YG, Higgins, D, Walsh, A, Shanahan-Prendergast, L and Lu, JH. (2009),
  Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.
  European Journal of Pharmaceutical Sciences 38(3), 215-223.
• Maltezou, HC and Tsiodras, S. (2009),
  Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options.
  Current Drug Targets 10(10), 1041-1048.
• Nicoletti, F, Conrad, D, Wang, A, Pieters, R, Mangano, K, van Heeckeren, A, White, SK, Frincke, J, Reading, CL, Auci, DL and Stickney, D. (2009),
  16 α-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs.
  Clinical and Experimental Immunology 158(3), 308-316.
• Ohigashi, Y, Ma, CL, Jing, XH, Balannick, V, Pinto, LH and Lamb, RA. (2009),
  An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
  Proceedings of the National Academy of Sciences of the United States of America 106(44), 18781-18785.
• Oshima, S, Nemoto, E, Kuramochi, M, Saitoh, Y and Kobayashi, D. (2009),
  Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice.
  Journal of Pharmacy and Pharmacology 61(10), 1397-1400.
• Rossignol, JF, La Frazia, S, Chiappa, L, Ciucci, A and Santoro, MG. (2009),
  Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.
  Journal of Biological Chemistry 284(43), 29798-29808.
• Rungrotmongkol, T, Udommaneethanakit, T, Malaisree, M, Nunthaboot, N, Intharathep, P, Sompornpisut, P and Hannongbua, S. (2009),
  How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?
  Biophysical Chemistry 145(1), 29-36.
• Selvam, P, Rathore, P, Karthikumar, S, Velkumar, K, Palanisamy, P, Vijayalakhsmi, S and Witvrouw, M. (2009),
  Synthesis and antiviral studies of novel N-Sulphonamidomethyl piperazinyl fluoroquinolones.
  Indian Journal of Pharmaceutical Sciences 71(4), 432-6.
• Singh, AA. (2009),
  Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.
  National Medical Journal of India 22(2), 103.
• Soderstrom, H, Jarhult, JD, Olsen, B, Lindberg, RH, Tanaka, H and Fick, J. (2009),
  Detection of the antiviral drug oseltamivir in aquatic environments.
  PLoS ONE 4(6), e6064.
• Tashiro, M, McKimm-Breschkin, JL, Saito, T, Klimov, A, Macken, C, Zambon, M and Hayden, FG. (2009),
  Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
  Antiviral Therapy 14(6), 751-761.
• Udommaneethanakit, T, Rungrotmongkol, T, Bren, U, Frecer, V and Stanislav, M. (2009),
  Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
  Journal of Chemical Information and Modeling 49(10), 2323-2332.
• Yang, ZW, Yang, G, Zu, YG, Fu, YJ and Zhou, LJ. (2009),
  The conformational analysis and proton transfer of neuraminidase inhibitors: a theoretical study.
  Physical Chemistry Chemical Physics 11(43), 10035-10041.
• Yong, JP, Aisa, HA and Nie, LF. (2009),
  Synthesis of rupestonic acid benzyl ester derivatives and in vitro anti influenza virus and herpes simplex type I and II viruses.
  Chinese Journal of Organic Chemistry 29(10), 1640-1644.

Back to top

Vaccination and vaccines

• Anonymous. (2009),
  Flu campaign receives excellence award: underscores importance of educating pregnant women about flu vaccination.
  Nursing for Women's Health 13(4), 349-50.
• Anonymous. (2009),
  Four H1N1 vaccines demonstrate safety and effectiveness, receive FDA approval.
  American Family Physician 80(8), 771.
• Anonymous. (2009),
  Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009.
  Weekly Epidemiological Record 84(32), 325-32.
• Agusto, FB and Gumel, AB. (2010),
  Theoretical assessment of avian influenza vaccine.
  Discrete and Continuous Dynamical Systems-Series B 13(1), 1-25.
• Alberini, I, Del Tordello, E, Fasolo, A, Temperton, NJ, Galli, G, Gentile, C, Montomoli, E, Hilbert, AK, Banzhoff, A, Del Giudice, G, Donnelly, JJ, Rappuoli, R and Capecchi, B. (2009),
  Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses.
  Vaccine 27(43), 5998-6003.
• Ambrozaitis, A, Groth, N, Bugarini, R, Sparacio, V, Podda, A and Lattanzi, M. (2009),
  A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.
  Vaccine 27(43), 6022-6029.
• Baldwin, SL, Shaverdian, N, Goto, Y, Duthie, MS, Raman, VS, Evers, T, Mompoint, F, Vedvick, TS, Bertholet, S, Coler, RN and Reed, SG. (2009),
  Enhanced humoral and Type 1 cellular immune responses with Fluzone (R) adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
  Vaccine 27(43), 5956-5963.
• Beasley, CD. (2009),
  Nurses must consider the benefits of having the swine flu vaccine.
  Nursing Times 105(34), 13.
• Biesova, Z, Miller, MA, Schneerson, R, Shiloach, J, Green, KY, Robbins, JB and Keith, JM. (2009),
  Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.
  Vaccine 27(44), 6234-6238.
• Bottcher, E, Freuer, C, Steinmetzer, T, Klenk, HD and Garten, W. (2008),
  MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
  Vaccine 27(45), 6324-6329.
• Broughton, DE, Beigi, RH, Switzer, GE, Raker, CA and Anderson, BL. (2009),
  Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy.
  Obstetrics and Gynecology 114(5), 981-987.
• Centers for Disease Control and Prevention. (2009),
  Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
  MMWR - Morbidity & Mortality Weekly Report 58(44), 1241-5.
• Clutterbuck, A, Jain, N and Simpson, D. (2009),
  Advancing vaccine technology to combat global pandemic threats.
  Biopharm International (Suppl.), 8-13.
• Doig, A. (2009),
  CMA on the vaccine plan.
  CMAJ Canadian Medical Association Journal 181(8), 500.
• Dong, J, Matsuoka, Y, Maines, TR, Swayne, DE, O'Neill, E, Davis, CT, Van-Hoven, N, Balish, A, Yu, HJ, Katz, JM, Klimov, A, Cox, N, Li, DX, Wang, Y, Guo, YJ, Yang, WZ, Donis, RO and Shu, YL. (2009),
  Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
  Influenza and Other Respiratory Viruses 3(6), 287-295.
• Dong, J-H, Chang, W-H and Tian, X-P. (2009),
  [Immunogenicity and safety of influenza split vaccine].
  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology 30(3), 310-1.
• Ebrahimi, SM, Aghaiypour, K, Nili, H, Esmailzadeh, M and Mirjalili, A. (2009),
  Construction of a pAED4-M2 vector for expressing avian influenza A (H9N2) virus M2 gene as a universal recombinant vaccine model.
  Turkish Journal of Veterinary & Animal Sciences 33(5), 401-406.
• Eisen, DP and McBryde, ES. (2009),
  Avoiding Guillan-Barre syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
  Journal of Infectious Diseases 200(10), 1627-8.
• Feng, JQ, Gulati, U, Zhang, XJ, Keitel, WA, Thompson, DM, James, JA, Thompson, LF and Air, GM. (2008),
  Antibody quantity versus quality after influenza vaccination.
  Vaccine 27(45), 6358-6362.
• Fiers, W, De Filette, M, El Bakkouri, K, Schepens, B, Roose, K, Schotsaert, M, Birkett, A and Saelens, X. (2008),
  M2e-based universal influenza A vaccine.
  Vaccine 27(45), 6280-6283.
• Garcon, N, Di Pasquale, A and Monteyne, P. (2009),
  Addressing unmet medical needs through tailored vaccine design: the importance of adjuvant systems.
  Biopharm International (Suppl.), 22-29.
• Griffiths, E. (2009),
  The H1N1 vaccine plan.
  CMAJ Canadian Medical Association Journal 181(8), 500.
• Hampton, T. (2009),
  H1N1 vaccine urged for health workers, but some resist getting on board.
  JAMA 302(17), 1848-9.
• Hebert, PC and MacDonald, N. (2009),
  The H1N1 vaccine race: can we beat the pandemic?
  CMAJ Canadian Medical Association Journal 181(8), E125-7.
• Holst, PJ, Christensen, JP and Thomsen, AR. (2008),
  [Avian influenza and perspectives on vaccination against pandemic influenza].
  Ugeskrift for Laeger 170(48), 3953-6.
• Hood, J and Smith, A. (2009),
  Developing a "best practice" influenza vaccination program for health care workers--an evidence-based, leadership-modeled program.
  AAOHN Journal 57(8), 308-12.
• Ichinohe, T, Ainai, A, Tashiro, M, Sata, T and Hasegawa, H. (2009),
  PolyI: polyC(12)U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.
  Vaccine 27(45), 6276-6279.
• Jadhao, SJ, Lee, CW, Sylte, M and Suarez, DL. (2009),
  Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
  Vaccine 27(44), 6247-6260.
• Johansen, K, Nicoll, A, Ciancio, BC and Kramarz, P. (2009),
  Pandemic influenza A(H1N1) 2009 vaccines in the European Union.
  Eurosurveillance 14(41), 12-18.
• Kattan, N and Wooding, FG. (2009),
  Influenza vaccine and the elderly.
  Consultant Pharmacist 24(9), 686-8.
• Kelso, JM. (2009),
  Update on vaccination guidelines for allergic children.
  Expert Review of Vaccines 8(11), 1541-1546.
• Kelso, JM, Li, JT, Bernstein, DI, Blessing-Moore, J, Cox, L, Khan, DA, Lang, DM, Nicklas, RA, Oppenheimer, J, Portnoy, JM, Randolph, C, Schuller, DE, Spector, SL, Tilles, SA, Wallace, D, Baker, J, Ballas, ZK, Bellanti, JA, Ein, D and Grammer, LC. (2009),
  Adverse reactions to vaccines.
  Annals of Allergy Asthma & Immunology 103(4, Suppl. 2), S1-S14.
• Kitikoon, P, Vincent, AL, Jones, KR, Nilubol, D, Yu, S, Janke, BH, Thacker, BJ and Thacker, EL. (2009),
  Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
  Veterinary Microbiology 139(3-4), 235-244.
• Kramarz, P, Ciancio, B and Nicoll, A. (2009),
  Seasonal and pandemic influenza vaccines for the elderly and other risk groups A review of available data.
  Polskie Archiwum Medycyny Wewnetrznej-Polish Archives of Internal Medicine 119(10), 654-658.
• Kreijtz, J, Suezer, Y, de Mutsert, G, van den Brand, JMA, van Amerongen, G, Schnierle, BS, Kuiken, T, Fouchier, RAM, Lower, J, Osterhaus, A, Sutter, G and Rimmelzwaan, GF. (2008),
  Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
  Vaccine 27(45), 6296-6299.
• Kresse, H and Rovini, H. (2009),
  Influenza vaccine market dynamics.
  Nature Reviews Drug Discovery 8(11), 841-2.
• Lau, JTF, Yeung, NCY, Choi, KC, Cheng, MYM, Tsui, HY and Griffiths, S. (2009),
  Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey.
  British Medical Journal 339, b4164.
• Laursen, AB. (2009),
  [Dangerous adjuvant in swine influenza vaccine].
  Ugeskrift for Laeger 171(43), 3122.
• Layton, SL, Kapczynski, DR, Higgins, S, Higgins, J, Wolfenden, AD, Liljebjelke, KA, Bottje, WG, Swayne, D, Berghman, LR, Kwon, YM, Hargis, BM and Cole, K. (2008),
  Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge.
  Poultry Science 88(11), 2244-2252.
• Ledwich, LJ, Harrington, TM, Ayoub, WT, Sartorius, JA and Newman, ED. (2009),
  Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert.
  Arthritis & Rheumatism-Arthritis Care & Research 61(11), 1505-1510.
• Li, Y-C and Liu, C-M. (2009),
  Threat-responsiveness and the decision to obtain free influenza vaccinations among the older adults in Taiwan.
  BMC Public Health 9, 275.
• Lindley, MC, Yonek, J, Ahmed, F, Perz, JF and Torres, GW. (2009),
  Measurement of influenza vaccination coverage among healthcare personnel in US hospitals.
  Infection Control and Hospital Epidemiology 30(12), 1150-1157.
• Mosshammer, D, Muche, R, Hermes, J, Zollner, I and Lorenz, G. (2009),
  [Factors associated with influenza vaccination information--a cross-sectional study in elderly primary care patients].
  Zeitschrift fur Evidenz Fortbildung und Qualitat im Gesundheitswesen 103(7), 445-51.
• Nichol, KL. (2008),
  Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy.
  Vaccine 27(45), 6305-6311.
• Nolan, T, Richmond, PC, McVernon, J, Skeljo, MV, Hartel, GF, Bennet, J and Basser, RL. (2009),
  Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children.
  Influenza and Other Respiratory Viruses 3(6), 315-325.
• Nowalk, MP, Tabbarah, M, Hart, JA, Fox, DE, Raymund, M, Wilson, SA and Zimmerman, RK. (2009),
  Office manager and nurse perspectives on facilitators of adult immunization.
  American Journal of Managed Care 15(10), 755-760.
• Nowalk, MP, Tabbarah, M, Terry, MA, Raymund, M, Wilson, SA, Fox, DE and Zimmerman, RK. (2009),
  Using quantitative and qualitative approaches to understand racial disparities in adult vaccination.
  Journal of the National Medical Association 101(10), 1052-1060.
• Orbach, H and Tanay, A. (2009),
  Vaccines as a trigger for myopathies.
  Lupus 18(13), 1213-1216.
• Romanova, J, Krenn, BM, Wolschek, M, Ferko, B, Romanovskaja-Romanko, E, Morokutti, A, Shurygina, A-P, Nakowitsch, S, Ruthsatz, T, Kiefmann, B, Konig, U, Bergmann, M, Sachet, M, Balasingam, S, Mann, A, Oxford, J, Slais, M, Kiselev, O, Muster, T and Egorov, A. (2009),
  Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.
  PLoS ONE 4(6), e5984.
• Ropero-Alvarez, AM, Kurtis, HJ, Danovaro-Holliday, MC, Ruiz-Matus, C and Andrus, JK. (2009),
  Expansion of seasonal influenza vaccination in the Americas.
  BMC Public Health 9, 361.
• Schwarz, TF, Horacek, T, Knuf, M, Damman, HG, Roman, F, Drame, M, Gillarde, P and Jilg, W. (2008),
  Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.
  Vaccine 27(45), 6284-6290.
• Simonsen, L, Viboud, C, Taylor, RJ, Miller, MA and Jackson, L. (2008),
  Influenza vaccination and mortality benefits: new insights, new opportunities.
  Vaccine 27(45), 6300-6304.
• Stafford, N. (2009),
  Only 12% of Germans say they will have H1N1 vaccine after row blows up over safety of adjuvants.
  BMJ 339, b4335.
• Sypsa, V, Pavlopoulou, I and Hatzakis, A. (2009),
  Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies.
  Eurosurveillance 14(41), 2-5.
• Traynor, K. (2009),
  Officials look toward fall for clinical data on pandemic vaccines.
  American Journal of Health-System Pharmacy 66(17), 1513-5.
• Tuppin, P, Samson, S, Weill, A, Ricordeau, P and Allemand, H. (2009),
  Influenza vaccination coverage in France in 2007-2008: contribution of vaccination refund data from the general health insurance scheme.
  Medecine Et Maladies Infectieuses 39(10), 780-788.
• van den Dool, C, Bonten, MJM, Hak, E and Wallinga, J. (2009),
  Modeling the effects of influenza vaccination of health care workers in hospital departments.
  Vaccine 27(44), 6261-6267.
• Vesikari, T, Groth, N, Karvonen, A, Borkowski, A and Pellegrini, M. (2008),
  MF59 (R)-adjuvanted influenza vaccine (FLUAD (R)) in children: safety and immunogenicity following a second year seasonal vaccination.
  Vaccine 27(45), 6291-6295.
• Wicker, S, Rabenau, HF, Kempf, VAJ and Brandt, C. (2009),
  Vaccination against classical influenza in health-care workers self-protection and patient protection.
  Deutsches Arzteblatt International 106(36), 567-72.
• Wu, F, Yuan, XY, Huang, WS and Chen, YH. (2009),
  Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
  Vaccine 27(43), 6095-6101.
• Xie, H, Liu, TM, Lu, XH, Wu, ZQ, Belser, JA, Katz, JM, Tumpey, TM and Ye, ZP. (2009),
  A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
  Journal of Infectious Diseases 200(12), 1874-1883.